<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-113436</identifier>
<setSpec>0214-1582</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">36th Annual San Antonio Breast Cancer Symposium: summary of the contributions with greatest clinical impact</dc:title>
<dc:description xml:lang="en">The San Antonio Breast Cancer Symposium, in which breast cancer management is updated from a multidisciplinary perspective, is considered the most important international meeting on breast cancer. Notable contributions this year included 10-year studies of adjuvant tamoxifen and a phase ii trial of letrozole with PD 0332991, a cyclin-dependent kinase 4/6 inhibitor. The present article summarizes, under distinct subheadings, the contributions with greatest clinical impact(AU)</dc:description>
<dc:creator>Gironés, Regina</dc:creator>
<dc:creator>Ruiz, Amparo</dc:creator>
<dc:creator>Torregrosa, María Dolores</dc:creator>
<dc:creator>Guerrero, Angel</dc:creator>
<dc:creator>Gavilá, Joaquin</dc:creator>
<dc:creator>López, Pedro</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La reunión anual del San Antonio Breast Cancer Symposium es considerada el evento internacional más importante que se realiza sobre cáncer de mama. En ella se actualiza la situación del manejo del cáncer de mama desde un punto de vista multidisciplinar. En esta edición destacan los trabajos de adyuvancia con tamoxifeno durante 10 años, así como los prometedores datos del estudio fase ii que combina letrozol con PD 0332991, un inhibidor de ciclina-dependiente de quinasa 4/6. Se resumen, agrupadas en epígrafes, las aportaciones de mayor impacto clínico(AU)</dc:description>
<dc:source>Rev. senol. patol. mamar. (Ed. impr.);26(2): 65-72, abr.-jun. 2013.</dc:source>
<dc:identifier>ibc-113436</dc:identifier>
<dc:title xml:lang="es">36th Annual San Antonio Breast Cancer Symposium: resumen de los conceptos clínicos más relevantes</dc:title>
<dc:subject>^d29627</dc:subject>
<dc:subject>^d30942</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3250^s22049</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d1968^s22080</dc:subject>
<dc:subject>^d3250^s22074</dc:subject>
<dc:subject>^d30193^s22039</dc:subject>
<dc:subject>^d3250^s22048</dc:subject>
<dc:subject>^d14010^s22073</dc:subject>
<dc:subject>^d30193^s22074</dc:subject>
<dc:subject>^d1968^s22054</dc:subject>
<dc:subject>^d1968^s22057</dc:subject>
<dc:subject>^d1968^s22059</dc:subject>
<dc:type>article</dc:type>
<dc:date>201306</dc:date>
</metadata>
</record>
</ibecs-document>
